−15JPY
−323.66 MJPY
1.90 BJPY
18.24 M
About RAQUALIA PHARMA INC
Sector
Headquarters
Nagoya
Employees (FY)
67
Website
Founded
2008
ISIN
JP3967150008
FIGI
BBG001JXTH14
RaQualia Pharma, Inc. engages in a research and development of pharmaceuticals. Its medicines focus on pain, gastrointestinal, auto-immune diseases, inflammation, cancer, and Alzheimer's. Its products include Anidulafungin, Dalbavancin, Ziprasidone, 5-HT4 Partial Agonist, and 5-HT2B Antagonist. The company was founded on February 19, 2008 and is headquartered in Nagoya, Japan.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of 4579 is 610 JPY — it has increased by 1.16% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on TSE exchange RAQUALIA PHARMA INC stocks are traded under the ticker 4579.
RAQUALIA PHARMA INC is going to release the next earnings report on May 15, 2024. Keep track of upcoming events with our Earnings Calendar.
4579 stock is 3.34% volatile and has beta coefficient of 0.11. Check out the list of the most volatile stocks — is RAQUALIA PHARMA INC there?
One year price forecast for RAQUALIA PHARMA INC has a max estimate of 1800 JPY and a min estimate of 1800 JPY.
4579 earnings for the last quarter are −5.05 JPY whereas the estimation was −5.00 JPY which accounts for −1.00% surprise. Estimated earnings for the next quarter are 9.00 JPY. See more details about RAQUALIA PHARMA INC earnings.
RAQUALIA PHARMA INC revenue for the last quarter amounts to 644.00 M JPY despite the estimated figure of 761.00 M JPY. In the next quarter revenue is expected to reach 345.00 M JPY.
Yes, you can track RAQUALIA PHARMA INC financials in yearly and quarterly reports right on TradingView.
4579 stock has fallen by 0.33% compared to the previous week, the month change is a 0.33% fall, over the last year RAQUALIA PHARMA INC has showed a 26.24% decrease.
No, 4579 doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, 4579 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RAQUALIA PHARMA INC stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 67.00 employees. See our rating of the largest employees — is RAQUALIA PHARMA INC on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RAQUALIA PHARMA INC technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RAQUALIA PHARMA INC stock shows the sell signal. See more of RAQUALIA PHARMA INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on RAQUALIA PHARMA INC future price: according to them, 4579 price has a max estimate of 1800.00 JPY and a min estimate of 1800.00 JPY. Read a more detailed RAQUALIA PHARMA INC forecast: see what analysts think of RAQUALIA PHARMA INC and suggest that you do with its stocks.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RAQUALIA PHARMA INC EBITDA is −161.80 M JPY, and current EBITDA margin is −8.51%. See more stats in RAQUALIA PHARMA INC financial statements.